Perioperative Management of Telmisartan/Amlodipine and Trimetazidine for TAHBSO
Continue amlodipine on the morning of surgery, but hold telmisartan on the day of surgery to avoid intraoperative hypotension; trimetazidine can be continued as it may provide myocardial protection.
Telmisartan (ARB) - Hold on Day of Surgery
The 2024 AHA/ACC perioperative guidelines emphasize continuing medications with established long-term indications, particularly beta blockers 1. However, angiotensin receptor blockers (ARBs) like telmisartan present a specific risk: they increase the likelihood of intraoperative hypotension that can be difficult to manage during surgery 2, 3.
Key considerations for telmisartan:
- Withhold on the morning of surgery to reduce hypotension risk
- The FDA labeling notes telmisartan can cause significant hypotension, especially in volume-depleted states (which surgery creates) 4
- While hypotension from ARBs typically responds to vasopressors, preventing it is preferable to treating it during a surgical procedure
- Resume 24-48 hours postoperatively once hemodynamic stability is confirmed and oral intake restored
Common pitfall: Some clinicians continue all cardiac medications uniformly. However, ARBs are the exception due to their specific mechanism of blocking compensatory responses to surgical stress and fluid shifts.
Amlodipine (Calcium Channel Blocker) - Continue
Continue amlodipine on the morning of surgery with a sip of water. The evidence strongly supports continuation of calcium channel blockers perioperatively 2, 3. Unlike ARBs, calcium channel blockers:
- Do not significantly increase intraoperative hypotension risk
- Provide cardiovascular stability during surgical stress
- Have no rebound hypertension with continuation
- The 2024 guidelines support continuing established cardiovascular medications when clinically appropriate 1
Trimetazidine - Continue
Continue trimetazidine through the perioperative period. This anti-ischemic metabolic agent has demonstrated cardioprotective effects in cardiac surgery:
- Reduces biochemical markers of myocardial injury (CK-MB, troponin T, myoglobin) during surgery 5
- Improves myocardial lactate extraction after cardioplegic arrest 5
- Enhances myocardial contractility and limits stunning in the postoperative period 6
- No evidence of adverse perioperative hemodynamic effects 5
While these studies focused on cardiac surgery, the myocardial protective mechanisms apply to any surgery with cardiovascular stress. Given its safety profile and potential benefit, continuation is reasonable.
Practical Implementation
Day before surgery: Take all three medications as usual
Morning of surgery:
- Take amlodipine with small sip of water
- Take trimetazidine with small sip of water
- HOLD telmisartan
Postoperative: Resume telmisartan once patient is hemodynamically stable, typically 24-48 hours post-op, when taking adequate oral fluids
This approach balances cardiovascular protection (amlodipine, trimetazidine) while minimizing the specific risk of ARB-induced intraoperative hypotension that could complicate anesthetic management during TAHBSO.